Morgan Stanley 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-11 12:58 pm Purchase | 2025-12-31 | 13G | C4 Therapeutics, Inc. CCCC | MORGAN STANLEY MS | 8,974,191 9.300% | 4,223,808 (+88.92%) | Filing |
| 2025-08-07 12:50 pm Purchase | 2025-06-30 | 13G | C4 Therapeutics, Inc. CCCC | MORGAN STANLEY MS | 4,750,383 6.700% | 921,573 (+24.07%) | Filing |
| 2025-02-03 1:59 pm Purchase | 2024-12-31 | 13G | C4 Therapeutics, Inc. CCCC | MORGAN STANLEY MS | 3,828,810 5.400% | 3,828,810 (New Position) | Filing |